The tablet comes in different strengths, and patients typically start at a low dose and increase it over time
For effective, evidence-based weight management, consult a healthcare provider about FDA-approved GLP-1 medications
Unlike semaglutide, which has established cardiovascular benefit data, retatrutides long-term cardiovascular profile remains under study
Some users of GH actually mistake this fluid accumulation for lean tissue gains

Approval (2017) Novo Nordisk Press Release (18th October, 2025): FDA Approves Novo Nordisk's Oral Semaglutide For Cardiovascular (CV) Risk Reduction In Adults With Type 2 Diabetes Who Are At High Risk, Including Those Who Have Not Had A Prior CV Event Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) Efficacy And Safety Of Once-Weekly Semaglutide 20 Mg Versus 10 Mg In Patients With Type 2 Diabetes (SUSTAIN FORTE): A Double-Blind, Randomised, Phase 3b Trial (July 19, 2021) Oral Semaglutide Versus Subcutaneous Liraglutide And Placebo In Type 2 Diabetes (PIONEER 4): A Randomised, Double-Blind, Phase 3a Trial Novo Nordisk Press Release (21st October, 2024) Novo Nordisk A/S: Oral Semaglutide Demonstrates A 14% Reduction In Risk Of Major Adverse Cardiovascular Events In Adults With Type 2 Diabetes In The SOUL Trial Efficacy And Safety Of Once-Weekly Semaglutide 20 Mg Versus 10 Mg In Patients With Type 2 Diabetes (Sustain Forte): A Double-Blind, Randomised, Phase 3b Trial Metabolic Dysfunction-Associated Steatohepatitis And Progression To Hepatocellular Carcinoma: A Literature Review (March 20th, 2024)

Some diabetes medications are not safe in pregnancy either, so this requires careful planning